About Denis Patrick
Form D filings for EvolveImmune Therapeutics Holding Company from 2020 to 2024 list Denis Patrick as director.
Denis Patrick first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Denis Patrick in the role, so the role may have started earlier or lasted longer.
EvolveImmune Therapeutics Holding Company, LLC
Director
2020 – 2024 · Branford, CT
Develops immune-based cancer treatments for patients with solid tumors and blood cancers.
Key Colleagues at Startups
The people Denis Patrick works with at each company, as listed on that company's latest Form D.
EvolveImmune Therapeutics Holding Company, LLC · Form D, Nov 1, 2024

Donmienne Leung
Director
IT
Ian Taylor
Director
DY
Derek Yoon
Director
SB
Stephen Bloch
Co-founder and Chief Executive Officer, director
JM
Jasmina Marjanovic
Director